Neuroprotective activity of L-theanine on 3-nitropropionic acid-induced neurotoxicity in rat striatum

International Journal of Neuroscience

Volumn 124, Issue 9, 2014, Pages 673-684

  Thangarajan, Sumathi ^a   Deivasigamani, Asha ^a   Natarajan, Suganya Sarumani ^a   Krishnan, Prasanna ^a   Mohanan, Sandhya Koombankallil ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Gliosis; Huntington's disease; Mitochondrial complex II; Oxidative stress

Indexed keywords

3 NITROPROPIONIC ACID; CATALASE; GLUTATHIONE; MALONALDEHYDE; MITOCHONDRIAL ENZYME; SUCCINATE DEHYDROGENASE; SUPEROXIDE DISMUTASE; THEANINE; 3-NITROPROPIONIC ACID; CONVULSANT AGENT; GLUTAMIC ACID DERIVATIVE; NEUROPROTECTIVE AGENT; NITRO DERIVATIVE; PROPIONIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL DEATH; CELL DEGENERATION; CELL INFILTRATION; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; FORCED SWIM TEST; GLIOSIS; GRIP STRENGTH; HISTOPATHOLOGY; HUNTINGTON DISEASE LIKE SYNDROME; IMMOBILITY; LIPID PEROXIDATION; LOCOMOTION; MALE; MONONUCLEAR CELL; MORRIS WATER MAZE TEST; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OPEN FIELD TEST; OXIDATIVE STRESS; RAT; ROTAROD TEST; ANIMAL; BRAIN; DRUG EFFECTS; EXPLORATORY BEHAVIOR; MAZE TEST; METABOLISM; MITOCHONDRION; MOTOR ACTIVITY; NEUROTOXICITY SYNDROMES; PATHOLOGY; WISTAR RAT;

ANIMALS; BODY WEIGHT; BRAIN; CATALASE; CONVULSANTS; CORPUS STRIATUM; EXPLORATORY BEHAVIOR; GLUTAMATES; GLUTATHIONE; LIPID PEROXIDATION; MALE; MAZE LEARNING; MITOCHONDRIA; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; NEUROTOXICITY SYNDROMES; NITRO COMPOUNDS; PROPIONATES; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

EID: 84896729502     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2013.872642     Document Type: Article

References (55)

1. Cowan CM, Raymond LA. Selective neuronal degeneration in Huntington's disease. Curr Top DevBiol 2006;75:25-71.
2. Beal MF, Brouillet E, Jenkins BG, et al. Neurochemical and his-tologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 1993;13:4181-92.
3. Alexi T, Hughes PE, Faull RLM, et al. 3-Nitropropionic acid's lethal triplet: cooperative pathways of neurodegeneration. Neu-roreport 1998;9(11):R57-64.
4. Fontaine MA, Geddes JW, Banks A, Butterfeld DA. Effect of exogenous and endogenous antioxidants on 3-nitropionic acid-induced in vivo oxidative stress and striatal lesions: insights into Huntington's disease. J Neurochem 2000;75(4):1709-15.
5. Binienda Z, Simmons C, Hussain S, et al. Effect of acute exposure to 3-nitropropionic acid on activities of endogenous an-tioxidants in the rat brain. Neurosci Lett 1998;251:173-6.
6. Tunez I, Montilla P, Del Carmen Munoz M, et al. Protective effect of nicotine on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington's diseases. Euro J Pharmacol 2004;504:169-75.
7. Terashima T, Takido J, Yokogoshi H. Time-dependent changes of amino acids in the serum, liver, brain and urine of rats administered with theanine. Biosci Biotechnol Biochem 1999;63:615-8.
8. Haskell CF, Kennedy DO, Milne AL, et al. The effects of L-theanine, caffeine and their combination on cognition and mood. Biol Psychol 2008;77(2):113-22.
9. Kelly SP, Gomez-Ramirez M, Montesi JL et al. L-Theanine and caffeine in combination affect human cognition as evidenced by oscillatory alpha-band activity and attention task performance. J Nutr 2008;138:1572S-77S.
10. Egashira N, Hayakawa K, Mishima K, et al. Neuroprotective effect of gamma-glutamylethylamide (theanine) on cerebral infarction in mice. Neurosci Lett 2004;363:58-61.
11. Cho HS, Kim S, Lee SY, et al. Protective effect of the green tea component, L-theanineon environmental toxins-induced neu-ronal cell death. Neurotoxicology 2008;29:656-62.
12. Kumar P, Kalonia H, Kumar A. Sesamol attenuate 3-nitropropionic acid-induced Huntington-like behavioral, biochemical, and cellular alterations in rats. J Asian Nat Prod Res 2009;11(5):439-50.
13. Kumar P, Kumar A. Effect of lycopene and epigallocatechin-3-gallate against 3-nitropropionic acid induced cognitive dysfunction and glutathione depletion in rat: a novel nitric oxide mechanism. Food Chem Toxicol 2009;47(10): 2522-30.
14. Kumar P, Kumar A. Possible neuroprotective effect of With-ania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease. J Med Food 2009;12:591-600.
15. Yokogoshi H, Kobayashi M, Mochizuki M, et al. Effect of theanine, c-glutamylethylamide, on brain monoamines and striatal dopamine release in coscious rats. Neurochem Res 1998;23:667-73.
16. Mason R. 200 mg of Zen. L-Theanine boosts alpha waves, promotes alert relaxation. Altern Complement Ther 2001;7(3):91-5.
17. Kakuda T, Yanase H, Utsunomiya K, et al. Protective effect of gamma-glutamylethylamide (theanine) on ischmic delayed neu-ronal death in gerbils. Neurosci Lett 2000;289:189-92.
18. Kakuda T. Neuroprotective effects of the green tea components theanine and catechins. Biol Pharm Bull 2002;25(12): 1513-8.
19. Frautschy SA, Hu W, Kim P, et al. Phenolic anti-infammatory antioxidant reversal of Ab-induced cognitive defcits and neu-ropathology. Neurobiol Aging 2001;22:993-1005.
20. Kumar P, Kumar A. Possible role of sertraline against 3-nitropropionic acid induced behavioral, oxidative stress and mi-tochondrial dysfunctions in rat brain. Prog Neuropsychophar-macol Biol Psychiatry 2009;33(1):100-8.
21. Nowak G, Szewczyk B, Wieronska JM, et al. Antidepressant like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats. Brain Res Bull 2003;61:159-64.
22. Porsolt RD, Anton G, Blavet N, et al. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 1978;47:379-91.
23. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-75.
24. H. Ohkawa, N. Ohishi, K. Yagi. Assay for lipid peroxides in animal tissues by thiobarbituric acid reactions. Anal Biochem 1979;95:351-8.
25. Moron M, Depierre JW, Mannervik BT. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 1979;582: 67-78.
26. Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974;47:469-74.
27. Sinha AK. Colorimetric assay of catalase. Anal Biochemc 1972;47:389-94.
28. Slater EC, Bonner WD. The effect of fuoride on the succinic oxidase. System Biochem J 1952;52(2):185-196.
29. Mandavilli BS, Boldogh I, Van Houten B. 3-Nitropropionic acid-induced hydrogen peroxide, mitochondrial DNA damage, and cell death are attenuated by BcL-2 overexpression in PC12 cells. Brain Res Mol Brain Res 2005;133(2):215-23.
30. Saydoff JA, Liu LS, Garcia RA, et al. Oral uridine pro-drug PN401 decreases neurodegeneration, behavioral impairment, weight loss and mortality in the 3-nitropropionic acid mi-tochondrial toxin model of Huntington's disease. Brain Res 2003;994(1):44-54.
31. Pubill D, Verdaguer E, Canudas AM, et al. Orphenadrine prevents 3-nitropropionic acid-induced neurotoxicity in vitro and in vivo. Br J Pharmacol 2001;132(3):693-702.
32. Nam E, Lee SM, Koh SE, et al. Melatonin protects against neu-ronal damage induced by 3-nitropropionic acid in rat striatum. Brain Res 2005;1046(1-2):90-6.
33. Palf S, Ferrante RJ, Brouillet E, et al. Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor defcits of Huntington's disease. J. Neurosci 1996;16(9):3019-25.
34. Koutouzis TK, Borlongan CV, Scorcia TA, et al. Systemic 3-nitrpropionic acid: long term effects on locomotor behavior. Brain Res 1994;646:242-6.
35. Hong JT, Ryu SR, Kim HJ, et al. Neuroprotective effect of green tea extract in experimental ischemia-reperfusion brain injury. Brain Res Bull 2000 53:743-9.
36. Hong JT, Ryu SR, Kim HJ, et al. Protective effect of green tea extract on ischemia/reperfusion-induced brain injury in Mongolian gerbils. Brain Res 2001 888:11-8.
37. Lee H, Bae JH, Lee SR. Protective effect of green tea polyphe-nol EGCG against neuronal damage and brain edema after unilateral cerebral ischemia in gerbils. J Neurosci Res 2004;77(6):892-900.
38. Mandel S, Weinreb O, Amit T, et al. Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3- gallate: implications for neurodegenerative diseases. J Neurochem 2004;88(6):1555-69.
39. Egashira N, Hayakawa K, Osajima M, et al. Involvement of GABA (A) receptors in the neuroprotective effect of thea-nine on focal cerebral ischemia in mice. J Pharmacol Sci 2007;105:211-4.
40. Nathan PJ, Lu K, Gray M, et al. The neuropharmacology of L-theanine (N-ethyl-L-glutamine): a possible neuroprotec-tive and cognitive enhancing agent. J Herb Pharmacother 2006;6(2):21-30.
41. Yamada T, Terashima T, Honma H, et al. Effects of theanine, a unique amino acid in tea leaves, on memory in a rat behavioral test. Biosci Biotechnol Biochem 2008;72:1356-9.
42. Egashira N, Ishigami N, PuF, et al. Theanine prevents memory impairment induced by repeated cerebral ischemia in rats. Phytother Res 2008;22:65-8.
43. Haskell CF, Kennedy DO, Milne AL, et al. The effects of L-theanine, caffeine and their combination on cognition and mood. Biol Psychol 2008;77(2):113-22.
44. Owen GN, Parnell H, De Bruin EA, et al. The combined effects of L-theanine and caffeine on cognitive performance and mood. Nutr Neurosci 2008;11(4):193-8.
45. Wakabayashi C, Numakawa T, Ninomiya M, et al. Behavioral and molecular evidence for psychotropic effects in L-Theanine. Psychopharmacology 2012;219(4):1099-109.
46. Kumar P, Kumar A. Possible neuroprotective effect of With-ania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease. J Med Food 2009(c);12:591-600.
47. Browne SE, Ferrante RJ, Beal M F. Oxidative stress in Hunt-ington's disease. Brain Pathol 1999;9(1):147-63.
48. Lafon-Cazal M, Pietri S, Culcasi M, Bockaert J. NMDA dependent superoxide production and neurotoxicity. Nature 1993;364(6437):535-7.
49. Kumar P, Kalonia H, Kumar A. Lycopene modulates nitric oxide pathways against 3-nitropropionic acid-induced neurotoxicity. Life Sci 2009;85(19-20):711-8.
50. Bhateja DK, Dhull DK, Gill A, et al. Peroxisome proliferator-activated receptor-a activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: possible neuroprotective mechanisms. Eur J Pharmacol 2012;674:33-43.
51. Tae Il Kim, Yong Kyung Lee, Sang Gi Park, et al. L-theanine, an amino acid in green tea, attenuates/?-amyloid-induced cognitive dysfunction and neurotoxicity: reduction in oxidative damage and inactivation of ERK/p38 kinase and NF-/cB pathways. Free Radic Biol Med 2009;47:1601-10.
52. Kumar P, Padi SS, Naidu PS, Kumar A. Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms. Behav Pharmacol 2006;17:485-92.
53. Cole CJ, Edmondson DE, Singer TP. Inactivation of suc-cinate dehydrogenase by 3-nitropropionic acid. J Biol Chem 1979;254:5161-7.
54. Fu YT, He FS, Zhang SL, Zhang JS. Lipid peroxidation in rats intoxicated with 3-nitropropionic acid. Toxicology 1995;33(3):327-31.
55. Kappus H. Overview of enzyme systems involved in biore-duction of drugs and in redox cycling. Biochem Pharmacol 1986;35(1):1-6.